Margin of safety of extended-duration transdermal buprenorphine solution following multiple-dose administrations to cats.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of veterinary pharmacology and therapeutics"
DOI: 10.1111/jvp.13051
Abstract: Transdermal buprenorphine solution (TBS) is approved for the control of postoperative pain in cats where a single preoperative dose provides 4 days of analgesia. It is administered as a unit dose of 8 mg to cats weighing… read more here.
Keywords: safety; transdermal buprenorphine; buprenorphine solution; dosing interval ... See more keywords
Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database
Sign Up to like & getrecommendations! Published in 2017 at "BMJ Open"
DOI: 10.1136/bmjopen-2017-015872
Abstract: Objectives Subcutaneous tumour necrosis factor alpha TNFαinhibitors (SC-TNFis) such as golimumab (GLM), adalimumab (ADA), etanercept (ETA) and certolizumab pegol (CZP) have been used for many years for the treatment of inflammatory arthritis. Non-adherence to therapy… read more here.
Keywords: dosing interval; database; necrosis factor; inflammatory arthritis ... See more keywords
Effect of delayed misoprostol dosing interval for induction of labor: a retrospective study
Sign Up to like & getrecommendations! Published in 2019 at "BMC Pregnancy and Childbirth"
DOI: 10.1186/s12884-019-2454-9
Abstract: BackgroundInduction of labor occurs in greater than 22% of all pregnancies in the United States. Previous studies have shown that misoprostol is more effective for induction than oxytocin or dinoprostone alone. The World Health Organization… read more here.
Keywords: vaginal delivery; vaginal misoprostol; dosing interval; effect delayed ... See more keywords